Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;128(6):795-804.
doi: 10.1111/bcpt.13579. Epub 2021 Mar 26.

Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding

Siri Amundsen  1   2 , Hedvig Nordeng  3 , Ole-Martin Fuskevåg  1   2 , Elisabet Nordmo  4 , Georg Sager  2 , Olav Spigset  5   6
Affiliations

Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding

Siri Amundsen et al. Basic Clin Pharmacol Toxicol. 2021 Jun.

Abstract

Clinical data on the transfer of triptans into human breast milk remain scarce. In a lactation study including 19 breastfeeding women with migraine, we examined the excretion of six different triptans into milk. Following intake of a single dose, each participant collected seven breast milk samples at predefined intervals up to 24 hours after dose. Triptan concentrations in milk were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Infant drug exposure was estimated by calculating the relative infant dose (RID). Twenty-two breast milk sample sets were obtained for sumatriptan (n = 8), rizatriptan (n = 5), zolmitriptan (n = 4), eletriptan (n = 3), almotriptan (n = 1) and naratriptan (n = 1). Based on the average concentration in milk throughout the day, estimated mean RIDs (with range in parenthesis) were as follows: eletriptan 0.6% (0.3%-0.8%), sumatriptan 0.7% (0.2%-1.8%), rizatriptan 0.9% (0.3%-1.4%), almotriptan 1.8% (-), zolmitriptan 2.1% (0.7%-5.3%) and naratriptan 5.0% (-). Infant drug exposure through breastfeeding appears to be low and indicates that use of the triptans in this study is compatible with breastfeeding. Naratriptan may not be first choice in breastfeeding mothers initiating triptans during the neonatal period.

Keywords: breast milk; breastfeeding; lactation study; migraine; pharmacokinetics; relative infant dose; triptans.

PubMed Disclaimer

References

REFERENCES

    1. Cameron C, Kelly S, Hsieh S-C, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 2015;55(Suppl 4):221-235.
    1. Johnston MM, Rapoport AM. Triptans for the management of migraine. Drugs 2010;70:1505-1518.
    1. Hoshiyama E, Tatsumoto M, Iwanami H, et al. Postpartum migraines: a long-term prospective study. Intern Med. 2012;51:3119-3123.
    1. Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23:197-205.
    1. Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011;12:443-451.